Business headlines from the Apex backend, organized by sectors and major public companies for faster market scanning.
The company is working to shift its Gemini-II artificial intelligence processor from proof-of-concept toward production readiness, pairing hardware claims with software tool development and additional pilot programs.
THE APEX TIMES
THE APEX TIMES
A recent market piece argues that massive planned infrastructure spending by Alphabet and Amazon is likely to translate into outsized demand for key computing components used to build AI systems, highlighting Nvidia and Micron.
THE APEX TIMES
A recent market analysis argues that McDonald’s is using beverage experimentation alongside operational simplification, while investors weigh whether that can materially change the company’s momentum.
THE APEX TIMES
The companies behind a Lyme disease vaccine candidate said the European Medicines Agency has validated their marketing authorization application, a procedural step that can move the review forward.
THE APEX TIMES
A Yahoo Finance investing post raised the idea that a more focused financial stock could outperform a diversified holding company like Berkshire Hathaway, arguing one alternative offers a “guaranteed” return, though key details were not included in the excerpt available for this story.
THE APEX TIMES
A Yahoo Finance recap of Uber’s Q2 earnings call said the company aligned with Wall Street on revenue expectations, while investor reaction turned negative as questions refocused on how durable growth and margins can be.
THE APEX TIMES
Speaking on the expansion of Uber’s Robotaxi effort in Japan, CEO Dara Khosrowshahi called the country a “terrific” market, underscoring how fast autonomous-driving pilots are becoming a defining battleground for ride-hailing companies and their partners.
THE APEX TIMES
A recent Yahoo Finance note argues Uber’s stock decline may be overdone, even as investors worry about how the company’s autonomous-vehicle efforts will translate into near-term financial results.
THE APEX TIMES
The brokerage resumed coverage of Salesforce with an “Overweight” rating and set a $250 price target, pointing to expectations that the company’s core business momentum improves in the second half of the year. Shares were also reported to be on track for a third straight week of gains.
